Johnson & Johnson announced on Friday that it is recalling nearly 47 million packages of Tylenol, Sudafed and other nonprescription drugs manufactured at a Pennsylvania facility. The latest recall affects certain lots of Tylenol, Benadryl and Sudafed products because of insufficient cleaning procedures, though the company does not believe that quality was impacted. The company also recalled certain lots of Rolaids tablets because they do not include certain labeling information.
The recalls are aimed at wholesalers in the U.S., the Caribbean and Brazil. Consumers do not have to take any action, the company said. Consumers who have the products can continue using them.
No comments:
Post a Comment